Psychiatric comorbidity in injecting drug users in Asia and Africa

Current Opinion in Psychiatry

Volumn 25, Issue 3, 2012, Pages 213-218

  Iskandar, Shelly ^a   Kamal, Rama ^b   De Jong, Cor A ^b  

^a PADJADJARAN UNIVERSITY   (Indonesia)

^b Nijmegen Institute for Scientist Practitioners in Addiction NISPA   (Netherlands)

Author keywords

Africa; Asia; HIV; injecting drug users; psychiatric comorbidity; substance use disorders

Indexed keywords

AMPHETAMINE; COCAINE; METHADONE;

ADJUSTMENT DISORDER; AFRICA; ANXIETY; ASIA; COCAINE DEPENDENCE; COMORBIDITY; DEPRESSION; DRUG DEPENDENCE; FATIGUE; HEADACHE; HEPATITIS C; HEROIN DEPENDENCE; HOSPITALIZATION; HUMAN; IMPULSIVENESS; INTRAVENOUS DRUG ABUSE; MEDICAL HISTORY; MENTAL DISEASE; METHADONE TREATMENT; MOOD DISORDER; MULTIPLE DRUG ABUSE; PATHOLOGICAL GAMBLING; PERSONALITY; POSTTRAUMATIC STRESS DISORDER; PRISONER; PSYCHOPATHY; QUALITY OF LIFE; RECURRENCE RISK; REVIEW; RISK FACTOR; SLEEP QUALITY; STIGMA; SUICIDE; TEMPERAMENT; TREATMENT REFUSAL;

AFRICA; ASIA; COMORBIDITY; HUMANS; MENTAL DISORDERS; PATIENT COMPLIANCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84859352281     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3283523d66     Document Type: Review

References (68)

1. Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372:1733-1745.
2. Bergenstrom AM, Abdul-Quader AS. Injection drug use, HIV and the current response in selected low-income and middle-income countries. AIDS 2010; 24 (Suppl 3):S20-S29.
3. Altice FL, Kamarulzaman A, Soriano VV, et al. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010; 376:367-387.
4. UNODC. World Drug Report 2011 (Sales no. E.11.XI.10). United Nations Publication; 2011.
5. Raguin G, Lepretre A, Ba I, et al. Drug use and HIV in West Africa: a neglected epidemic. Trop Med Int Health 2011; 16:1131-1133.
6. Strathdee SA, Hallett TB, Bobrova N, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet 2010; 376:268-284.
7. Gruber VA, McCance-Katz EF. Methadone, buprenorphine, and street drug interactions with antiretroviral medications. Curr HIV/AIDS Rep 2010; 7:152-160.
8. Zahari MM, Hwan Bae W, Zainal NZ, et al. Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia. Am J Drug Alcohol Abuse 2010; 36:31-38.
9. Feizzadeh A, Nedjat S, Asghari S, et al. Evidence-based approach to HIV/ AIDS policy and research prioritization in the Islamic Republic of Iran. East Mediterr Health J 2010; 16:259-265.
10. Carpentier PJ, Krabbe PF, van Gogh MT, et al. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict 2009; 18:470-480.
11. Gu J, Lau JT, Chen H, et al. Mental health and interpersonal factors associated with HIV-related risk behaviors among noninstitutionalized female injection drug users who are also sex workers in China. Women Health 2010; 50:20-36.
12. Yen CN, Wang CS, Wang TY, et al. Quality of life and its correlates among heroin users in Taiwan. Kaohsiung J Med Sci 2011; 27:177-183.
13. Erfan S, Hashim AH, Shaheen M, et al. Effect of comorbid depression on substance use disorders. Subst Abus 2010; 31:162-169.
14. Gu J, Lau JT, Chen H, et al. Prevalence and factors related to syringe sharing behaviours among female injecting drug users who are also sex workers in China. Int J Drug Policy 2010; 22:26-33.
15. Liao Y, Tang J, Liu T, et al. A pilot study of life events and mood disorders: selfreport survey in chinese heroin-dependent individuals. Am J Addict 2011; 20:337-342.
16. Liao Y, Tang J, Liu T, et al. Sleeping problems among Chinese heroindependent individuals. Am J Drug Alcohol Abuse 2011; 37:179-183.
17. Onifade PO, Somoye EB, Ogunwobi OO, et al. A descriptive survey of types, spread and characteristics of substance abuse treatment centers in Nigeria. Subst Abuse Treat Prev Policy 2011; 6:25.
18. Peles E, Schreiber S, Linzy S, et al. Pathological gambling in methadone maintenance clinics where gambling is legal versus illegal. Am J Orthopsychiatry 2010; 80:311-316.
19. Sarin E, Samson L, Sweat M, et al. Human rights abuses and suicidal ideation among male injecting drug users in Delhi, India. Int J Drug Policy 2011; 22:161-166.
20. Maremmani AG, Dell'Osso L, Pacini M, et al. Dual diagnosis and chronology of illness in treatment-seeking Italian patients dependent on heroin. J Addict Dis 2011; 30:123-135.
21. Jones DL, Waldrop-Valverde D, Gonzalez P, et al. Mental health in HIV seronegative and seropositive IDUs in South Florida. AIDS Care 2010; 22:152-158.
22. Schafer I, Eiroa-Orosa FJ, Verthein U, et al. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment. Psychopathology 2010; 43:88-95.
23. Hopwood CJ, Morey LC, Skodol AE, et al. Pathological personality traits among patients with absent, current, and remitted substance use disorders. Addict Behav 2011; 36:1087-1090.
24. Staiger PK, Kambouropoulos N, Dawe S. Should personality traits be considered when refining substance misuse treatment programs? Drug Alcohol Rev 2007; 26:17-23.
25. Ruiz MA, Pincus AL, Schinka JA. Externalizing pathology and the five-factor model: a meta-analysis of personality traits associated with antisocial personality disorder, substance use disorder, and their co-occurrence. J Pers Disord 2008; 22:365-388.
26. Somer E. Prediction of abstinence from heroin addiction by childhood trauma, dissociation, and extent of psychosocial treatment. Addict Res Theory 2003; 11:339-348. (Pubitemid 37414714)
27. Wang Z, Du J, Sun H, et al. Patterns of childhood trauma and psychological distress among injecting heroin users in China. PLoS One 2010; 5:e15882.
28. Schiff M, Levit S, Cohen-Moreno R. Childhood sexual abuse, posttraumatic stress disorder, and use of heroin among female clients in Israeli methadone maintenance treatment programs (MMTPS). Soc Work Healthcare 2010; 49:799-813.
29. McCurdy SA, Ross MW, Williams ML, et al. Flashblood: blood sharing among female injecting drug users in Tanzania. Addiction 2010; 105:1062-1070.
30. Nada KH, Suliman el DA. Violence, abuse, alcohol and drug use, and sexual behaviors in street children of Greater Cairo and Alexandria, Egypt. AIDS 2010; 24 (Suppl 2):S39-44.
31. Cosci F, Fava GA. New clinical strategies of assessment of comorbidity associated with substance use disorders. Clin Psychol Rev 2011; 31:418-427.
32. Weich L, Pienaar W. Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa. Afr J Psychiatry (Johannesbg) 2009; 12:213-217.
33. Conner KR, Pinquart M, Duberstein PR. Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs). Addiction 2008; 103:524-534. (Pubitemid 351389274)
34. Poudel KC, Poudel-Tandukar K, Yasuoka J, et al. Correlates of sharing injection equipment among male injecting drug users in Kathmandu, Nepal. Int J Drug Policy 2010; 21:507-510.
35. Wobrock T, Sittinger H, Behrendt B, et al. Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 2007; 257:203-210. (Pubitemid 47036718)
36. Li L, Sangthong R, Chongsuvivatwong V, et al. Lifetime multiple substance use pattern among heroin users before entering methadone maintenance treatment clinic in Yunnan, China. Drug Alcohol Rev 2010; 29:420-425.
37. Iskandar S, Basar D, Hidayat T, et al. High risk behavior for HIV transmission among former injecting drug users: a survey from Indonesia. BMC Public Health 2010; 10:472.
38. Basu D. Overview of substance abuse and hepatitis C virus infection and co-infections in India. J Neuroimmune Pharmacol 2010; 5:496-506.
39. Vicknasingam B, Mazlan M, Schottenfeld RS, et al. Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia. Drug Alcohol Depend 2010; 111:44-49.
40. Solomon SS, Desai M, Srikrishnan AK, et al. The profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions. Subst Use Misuse 2010; 45:354-367.
41. Peles E, Schreiber S, Adelson M. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend 2010; 107:141-148.
42. Peltzer K, Ramlagan S, Johnson BD, et al. Illicit drug use and treatment in South Africa: a review. Subst Use Misuse 2010; 45:2221-2243.
43. Bao YP, Liu ZM, Lu L. Review of HIV and HCV infection among drug users in China. Curr Opin Psychiatry 2010; 23:187-194.
44. Jia Z, Wang W, Dye C, et al. Exploratory analysis of the association between new-type drug use and sexual transmission of HIV in China. Am J Drug Alcohol Abuse 2010; 36:130-133.
45. Martin M, Vanichseni S, Suntharasamai P, et al. Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003. Int J Drug Policy 2010; 21:296-301.
46. Mahanta J, Borkakoty B, Das HK, et al. The risk of HIV and HCV infections among injection drug users in northeast India. AIDS Care 2009; 21:1420-1424.
47. Weissenborn K, Tryc AB, Heeren M, et al. Hepatitis C virus infection and the brain. Metab Brain Dis 2009; 24:197-210.
48. Asnis GM, De La Garza R 2nd. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol 2006; 40:322-335. (Pubitemid 44309525)
49. Kaul M, Lipton SA. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 2006; 1:138-151. (Pubitemid 44257489)
50. Judd F, Komiti A, Chua P, et al. Nature of depression in patients with HIV/ AIDS. Aust N Z J Psychiatry 2005; 39:826-832. (Pubitemid 43904477)
51. Thirthalli J, Chand PK. The implications of medication development in the treatment of substance use disorders in developing countries. Curr Opin Psychiatry 2009; 22:274-280.
52. Gannon P, Khan MZ, Kolson DL. Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 2011; 24:275-283.
53. Pumpradit W, Ananworanich J, Lolak S, et al. Neurocognitive impairment and psychiatric comorbidity in well controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study. J Neurovirol 2010; 16:76-82.
54. Kresina TF, Normand J, Khalsa J, et al. Addressing the need for treatment paradigms for drug-abusing patients with multiple morbidities. Clin Infect Dis 2004; 38 (Suppl 5):S398-401. (Pubitemid 38738537)
55. Sylvestre DL, Loftis JM, Hauser P, et al. Co-occurring hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. J Urban Health 2004; 81:719-734. (Pubitemid 39457952)
56. Friedland G. Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis. J Acquir Immune Defic Syndr 2010; 55 (Suppl 1):S37-42.
57. Golub ET, Astemborski JA, Hoover DR, et al. Psychological distress and progression to AIDS in a cohort of injection drug users. J Acquir Immune Defic Syndr 2003; 32:429-434. (Pubitemid 36363158)
58. Sorsdahl KR, Mall S, Stein DJ, et al. Perspectives towards mental illness in people living with HIV/AIDSin South Africa. AIDS Care 2010; 22:1418-1427.
59. Werb D, Mills EJ, Montaner JS, et al. Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis. Lancet Infect Dis 2010; 10:464-469.
60. Wisaksana R, Indrati AK, Fibriani A, et al. Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia. Addiction 2010; 105:1055-1061.
61. Latkin C, Srikrishnan AK, Yang C, et al. The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India. Drug Alcohol Depend 2011; 110:221-227.
62. Kimber J, Mattick RP, Kaldor J, et al. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Drug Alcohol Rev 2008; 27:602-612.
63. Biddle L, Gunnell D, Sharp D, et al. Factors influencing help seeking in mentally distressed young adults: a cross-sectional survey. Br J Gen Pract 2004; 54:248-253. (Pubitemid 38461148)
64. Amato L, Minozzi S, Davoli M, et al. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev 2011; 9:CD005031.
65. Xiao L, Wu Z, Luo W, et al. Quality of life of outpatients in methadone maintenance treatment clinics. J Acquir Immune Defic Syndr 2010; 53 (Suppl 1): S116-S120.
66. Mathers BM, Degenhardt L, Ali H, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010; 375:1014-1028.
67. Myers BJ, Louw J, Pasche SC. Inequitable access to substance abuse treatment services in Cape Town, South Africa. Subst Abuse Treat Prev Policy 2010; 5:28.
68. dos Santos MM, Rataemane ST, Fourie D, et al. An approach to heroin use disorder intervention within the South African context: a content analysis study. Subst Abuse Treat Prev Policy 2010; 5:13.